Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 150.90 INR
Change Today -7.55 / -4.76%
Volume 67.1K
RPGL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

rpg life sciences ltd (RPGL) Snapshot

Open
158.80
Previous Close
158.45
Day High
158.80
Day Low
150.10
52 Week High
04/8/15 - 175.70
52 Week Low
05/7/14 - 64.60
Market Cap
2.5B
Average Volume 10 Days
92.1K
EPS TTM
0.60
Shares Outstanding
16.5M
EX-Date
09/11/14
P/E TM
251.5x
Dividend
1.20
Dividend Yield
1.32%
Current Stock Chart for RPG LIFE SCIENCES LTD (RPGL)

Related News

No related news articles were found.

rpg life sciences ltd (RPGL) Related Businessweek News

No Related Businessweek News Found

rpg life sciences ltd (RPGL) Details

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic and fermentation active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic/anti-depressant, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer. It also provides generics primarily in the area of immunosuppressant therapy; finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brand names; and biotechnology products in the areas of oncology. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is based in Mumbai, India.

Founded in 1968

rpg life sciences ltd (RPGL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rpg life sciences ltd (RPGL) Key Developments

RPG Life Sciences Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

RPG Life Sciences Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company has posted net sales of INR 611.9 million against INR 511.4 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 54.2 million against loss from operations before other income, finance costs and exceptional items was INR 3.3 million a year ago. Profit from ordinary activities before tax was INR 47.0 million against loss from ordinary activities before tax was INR 6.6 million a year ago. Net profit was INR 47.0 million or INR 3.04 basic and diluted per share against net loss of INR 5.1 million or INR 0.31 basic and diluted per share a year ago. For the year, the company has posted net sales of INR 2,330.8 million against INR 2,293.8 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 28.1 million against INR 10.7 million a year ago. Profit from ordinary activities before tax was INR 10.0 million against INR 649.7 million a year ago. Net profit was INR 100 million or INR 0.50 basic and diluted per share against INR 649.7 million or INR 32.29 basic and diluted per share a year ago.

RPG Life Sciences Ltd Recommends Dividend for the Year Ended March 31, 2015

RPG Life Sciences Ltd. recommended an equity dividend of INR 0.80 per share (10%) for the year ended March 31, 2015, subject to the approval of the shareholders at the ensuing Annual General Meeting.

RPG Life Sciences Limited, Board Meeting, Apr 29, 2015

RPG Life Sciences Limited, Board Meeting, Apr 29, 2015. Agenda: To consider audited financial results for the year ended March 31, 2015; and to recommend dividend for fiscal 2015, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPGL:IN 150.90 INR -7.55

RPGL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RPGL.
View Industry Companies
 

Industry Analysis

RPGL

Industry Average

Valuation RPGL Industry Range
Price/Earnings 100.0x
Price/Sales 1.0x
Price/Book 1.9x
Price/Cash Flow 20.2x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RPG LIFE SCIENCES LTD, please visit www.rpglifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.